Characterizing the Mechanism of DPP8/9 Inhibitor-Induced Pyroptosis
Characterizing the Mechanism of DPP8/9 Inhibitor-Induced Pyroptosis
批准号:
10733874
负责人:
Daniel Bachovchin
金额:
$52.38万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
未结题
起止时间:
2018-02-23 至 2028-05-31
关键词:
AccelerationAffectAmino Acid SequenceAmino AcidsAreaAutoimmune DiseasesBiologyC-terminalCancer EtiologyCell DeathCellsCellular Metabolic ProcessCellular StructuresCommunicable DiseasesComplexCysteineDataDipeptidesDipeptidyl PeptidasesDiseaseFoundationsFutureHealthHomeostasisHumanImmune responseImmunityInflammasomeInflammatoryInnate Immune SystemKnowledgeLaboratoriesLengthLigand BindingLinkLyticMalignant NeoplasmsMass Spectrum AnalysisMediatingMetabolicMetabolic DiseasesMetabolic dysfunctionMitochondriaMolecularMonitorMultiprotein ComplexesN-terminalNatural ImmunityNeurodegenerative DisordersOxidation-ReductionPaperPattern recognition receptorPeptidesPlayPrintingProcessProlineProtein RegionProteinsProteomicsPublic HealthReactive Oxygen SpeciesReportingRepressionResearchResearch Project GrantsSerineSignal TransductionStressT-LymphocyteTherapeuticWorkdisulfide bondhuman diseaseinhibitormulticatalytic endopeptidase complexpathogenpeptidomimeticsprotein degradationreceptor bindingsmall molecule
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Several human pattern-recognition receptors detect intracellular danger-associated signals, oligomerize into
multiprotein complexes called inflammasomes, and trigger a lytic form of cell death called pyroptosis.
Inflammasomes are involved in mounting immune responses to pathogens and in maintaining organismal
homeostasis, but their hyperactivation can cause cancer, autoimmune disorders, and metabolic dysfunction. As
such, it is critically important to characterize the molecular mechanisms that regulate inflammasome activation.
NLRP1 and CARD8 are related pattern-recognition receptors that form inflammasomes, but the danger signals
that they sense have not been fully established. Notably, ligands that bind to the serine dipeptidyl peptidases 8
and 9 (DPP8/9), including endogenous peptides with Xaa-Pro (where Xaa is any amino acid) N-termini, have
been reported to activate these inflammasomes. However, why the innate immune system monitors Xaa-Pro
peptide levels is unknown and constitutes a major knowledge gap. Recently, reductive stress, or a profound
lack of reactive oxygen species (ROS), was also reported to activate the NLPR1 and CARD8 inflammasomes.
The central hypothesis of this application is that reductive stress and Xaa-Pro peptide accumulation are
intimately related danger signals that together comprise an overall “danger state” that causes rapid and full
NLRP1 and CARD8 inflammasome activation. Specifically, it is proposed that the disordered regions of many
cytosolic proteins, including the autoinhibitory N-terminal region of CARD8, are stabilized by intramolecular
disulfide bonds; reductive stress abolishes these bonds, destabilizing these sequences and triggering their
degradation into peptides by the proteasome. Proline is the most abundant amino acid in disordered protein
regions, and therefore reductive stress likely generates many Xaa-Pro peptides. In this way, Xaa-Pro peptide
accumulation can serve to confirm that reductive stress is occurring. This central hypothesis has been
formulated based on preliminary data produced in the applicant’s laboratory and described in this application.
The objective of this project is to determine the relationship between reductive stress, disordered protein
degradation, and Xaa-Pro peptide accumulation. This project consists of three Specific Aims: 1) to determine
how reductive stress induces the proteasome-mediated degradation of CARD8, 2) to characterize the
relationship between reductive stress and Xaa-Pro peptide accumulation, and 3) to determine the relationship
between cell metabolism and inflammasome activation. The successful completion of this work will not only
clarify the primordial function of these enigmatic inflammasomes, but will also reveal a previously unknown a
connection between intracellular redox state and protein stability. Moreover, this work will provide the
foundation for future efforts to therapeutically control these inflammasomes for the treatment of human disease.
期刊论文(19)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.celrep.2022.111965
发表时间:
2023-01
期刊:
Cell reports
影响因子:
8.8
作者:
[Elizabeth L. Orth-He;Hsin-Che Huang;Sahana D. Rao;Qinghui Wang;Qifeng Chen;Claire M. O’Mara;Ashley J. Chui;Michelle Saoi;A. R. Griswold;A. Bhattacharjee;D. Ball;J. Cross;D. Bachovchin]
通讯作者:
Elizabeth L. Orth-He;Hsin-Che Huang;Sahana D. Rao;Qinghui Wang;Qifeng Chen;Claire M. O’Mara;Ashley J. Chui;Michelle Saoi;A. R. Griswold;A. Bhattacharjee;D. Ball;J. Cross;D. Bachovchin
DPP8/9 are not Required to Cleave Most Proline-Containing Peptides.
切割大多数含脯氨酸的肽不需要 DPP8/9。
DOI:
10.1002/ijch.202200117
发表时间:
2023
期刊:
Israel journal of chemistry
影响因子:
3.2
作者:
[Bhattacharjee,Abir, Bachovchin,DanielA]
通讯作者:
Bachovchin,DanielA
DOI:
10.1016/j.celrep.2020.108264
发表时间:
2020-10-13
期刊:
Cell reports
影响因子:
8.8
作者:
[Chui AJ, Griswold AR, Taabazuing CY, Orth EL, Gai K, Rao SD, Ball DP, Hsiao JC, Bachovchin DA]
通讯作者:
Bachovchin DA
The NLRP1 and CARD8 inflammasomes detect reductive stress.
NLRP1和CARD8炎症体检测还原应力。
DOI:
10.1016/j.celrep.2022.111966
发表时间:
2023-01-31
期刊:
Cell reports
影响因子:
8.8
作者:
[]
通讯作者:
DOI:
10.1016/j.immuni.2021.04.024
发表时间:
2021-07-13
期刊:
Immunity
影响因子:
32.4
作者:
[Sharif H, Hollingsworth LR, Griswold AR, Hsiao JC, Wang Q, Bachovchin DA, Wu H]
通讯作者:
Wu H
共 12 条
Prolidase Inhibitors as Therapeutic Agents for Acute Myeloid Leukemia
-
批准号:10342970
-
项目类别:
-
资助金额:$64.12万
-
财政年份:2022
-
负责人:Daniel Bachovchin
-
依托单位:
Prolidase Inhibitors as Therapeutic Agents for Acute Myeloid Leukemia
-
批准号:10573212
-
项目类别:
-
资助金额:$62.83万
-
财政年份:2022
-
负责人:Daniel Bachovchin
-
依托单位:
Redox control of the NLRP1 inflammasome
-
批准号:10430270
-
项目类别:
-
资助金额:$51.23万
-
财政年份:2021
-
负责人:Daniel Bachovchin
-
依托单位:
Redox control of the NLRP1 inflammasome
-
批准号:10621191
-
项目类别:
-
资助金额:$51.23万
-
财政年份:2021
-
负责人:Daniel Bachovchin
-
依托单位:
Redox control of the NLRP1 inflammasome
-
批准号:10277155
-
项目类别:
-
资助金额:$51.23万
-
财政年份:2021
-
负责人:Daniel Bachovchin
-
依托单位:
Characterizing the Mechanism of DPP8/9 Inhibitor-Induced Pyroptosis
-
批准号:10334478
-
项目类别:
-
资助金额:$44.9万
-
财政年份:2018
-
负责人:Daniel Bachovchin
-
依托单位:
Characterizing the Mechanism of DPP8/9 Inhibitor-Induced Pyroptosis
-
批准号:10091387
-
项目类别:
-
资助金额:$44.9万
-
财政年份:2018
-
负责人:Daniel Bachovchin
-
依托单位:
海外基金